Aurobindo Pharma’s arm restarts Penicillin-G manufacturing facility in AP

30 Jun 2025 Evaluate

Aurobindo Pharma’s wholly owned stepdown subsidiary -- Lyfius Pharma has re-started the production at its Penicillin-G manufacturing facility, at Kakinada, Andhra Pradesh (AP), with immediate effect, after receiving the consent to operate (CTO) from Andhra Pradesh from Andhra Pradesh Pollution Control Board (APPCB), on June 29, 2025.

Aurobindo Pharma is engaged in manufacturing pharmaceutical products. It offers active pharmaceutical ingredients, intermediates and generic formulations like astemizole, domeperidone and omeprazole; anti-infective, oral and sterile antibiotics, pain management and osteoporosis segments.

Aurobindo Pharma Share Price

1205.95 -6.70 (-0.55%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×